Acyclovir
- Product NDC
- 55289-462
- 11-digit product format
- 552890462
- Labeler code
- 55289
- Product ID
- 55289-462_7bc02915-7881-c23b-e053-2a91aa0ac766
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Acyclovir
- Dosage form
- TABLET
- Route
- ORAL
- Labeler
- PD-Rx Pharmaceuticals, Inc.
- Application
- ANDA074556
- Marketing category
- ANDA
- Marketing start
- 1997-04-23
- Marketing end
- 0000-00-00
- Substance
- ACYCLOVIR
- Active strength
- 400 mg/1
- Pharmacologic classes
- DNA Polymerase Inhibitors [MoA],Herpes Simplex Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC],Herpes Zoster Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC],Herpesvirus Nucleoside Analog DNA Polymerase Inhibitor [EPC],Nucleoside Analog [EXT]
- NDC exclude flag
- No
- Listing certified through
- 2019-12-31
- Current FDA listing
- Historical FDA.report record
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 55289-462-05 | EA - Each | 55289-462 | 2f36b3f2-72ac-4727-8a17-6ef18850acb6 | 1 | 2012-07-24 |
| 55289-462-12 | EA - Each | 55289-462 | 9ab92a75-85e2-4401-8db8-e893968ca45c | 1 | 2012-07-24 |
| 55289-462-15 | EA - Each | 55289-462 | ffe89fc5-7c57-4384-8c60-4f0741fb39c1 | 1 | 2012-07-24 |
| 55289-462-21 | EA - Each | 55289-462 | 375ad343-0486-49db-9777-0edf56747ef7 | 1 | 2012-07-24 |
| 55289-462-25 | EA - Each | 55289-462 | 5402f7bf-3972-4c6e-b9cf-51dee39317fe | 1 | 2012-07-24 |
| 55289-462-30 | EA - Each | 55289-462 | 1356cff4-f8ac-451e-b06f-817119100d37 | 1 | 2012-07-24 |
| 55289-462-35 | EA - Each | 55289-462 | c4849d52-1d7c-463a-a404-f72c03806372 | 1 | 2012-07-24 |
| 55289-462-40 | EA - Each | 55289-462 | fb6ed780-cf44-43cd-a097-eca882969118 | 1 | 2014-08-01 |
| 55289-462-60 | EA - Each | 55289-462 | b9bb4f85-dafd-40c3-9d94-a1e199746bdd | 1 | 2012-07-24 |